Central nervous system involvement in whipple disease: Clinical study of 18 patients and long-term follow-up

Medicine (United States)

Volumn 92, Issue 6, 2013, Pages 324-330

  Compain, Caroline ^a   Sacre, Karim ^b   Puéchal, Xavier ^a   Klein, Isabelle ^a   Vital Durand, Denis ^c   Houeto, Jean Luc ^d   De Broucker, Thomas ^e   Raoult, Didier ^f   Papo, Thomas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ DE POITIERS   (France)

^e Saint Denis Hospital   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TUBERCULOSTATIC AGENT;

ADULT; AGED; AMNESIA; ANTIMICROBIAL THERAPY; ARTICLE; ASEPTIC MENINGITIS; ATTENTION DISTURBANCE; BRAIN ATROPHY; BRAIN BIOPSY; BRAIN DISEASE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID CYTOLOGY; CHOREA; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMA; CONFUSION; DELIRIUM; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUODENUM BIOPSY; EARLY DIAGNOSIS; ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; FRONTAL LOBE SYNDROME; HEADACHE; HUMAN; HUMAN TISSUE; HYPERSOMNIA; HYPOTHALAMUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTESTINE LIPODYSTROPHY; LUNG INFECTION; MALE; MENINGITIS; MENINGOENCEPHALITIS; MESENCEPHALON; MONOTHERAPY; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MYELITIS; MYOCLONUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOMASTICATORY MYORHYTHMIA; OPHTHALMOPLEGIA; OUTCOME ASSESSMENT; PERIODIC ACID SCHIFF STAIN; PERIVENTRICULAR DIFFUSE LEUKOPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; PYRAMIDAL SIGN; RELAPSE; RETROSPECTIVE STUDY; SLEEP DISORDER; SPINAL CORD DISEASE; TEMPORAL LOBE; THALAMUS; TROPHERYMA WHIPPELII;

ADULT; AGED; ANTI-INFECTIVE AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TROPHERYMA; WHIPPLE DISEASE;

EID: 84887845625     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000010     Document Type: Article

References (31)

1. Agard C, Brisseau JM, Grossi O, Pattier S, Espitia-Thibault A, Le Goff B, Audrain M, Ponge T, Hamidou M. Two cases of atypical Whipple's disease associated with cytoplasmic ANCA of undefined specificity. Scand J Rheumatol. 2012;41:246-248.
2. Besnard S, Cady A, Flecher S, Fily F, Revest M, Arvieux C, Donnio PY, Michelet C, Tattevin P. Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis? Am J Med. 2010;123:962, e961-964.
3. Black DF, Aksamit AJ, Morris JM. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am J Neuroradiol. 2010;31:1493-1497.
4. Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747-752.
5. Dobbins WO III. The diagnosis of Whipple's disease. N Engl J Med. 1995;332:390-392.
6. Drancourt M, Raoult D, Lepidi H, Fenollar F, Birg ML, Bodaghi B, Hoang PL, Lelievre JD. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann Intern Med. 2003;139:1046-1047.
7. Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997;76:170-184.
8. El Helou J, Saliba G, Kolev I, Pierrot-Deseilligny C. Neuro-Whipple confirmed five years after a presumptive diagnosis of a primitive CNS vasculitis. J Neurol. 2008;255:925-926.
9. Famularo G, Minisola G, De Simone C. A patient with cerebral Whipple's disease and a stroke-like syndrome. Scand J Gastroenterol. 2005;40:607-609.
10. Fenollar F, Laouira S, Lepidi H, Rolain JM, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis. 2008;47:659-667.
11. Fenollar F, Nicoli F, Paquet C, Lepidi H, Cozzone P, Antoine JC, Pouget J, Raoult D. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis. BMC Infect Dis. 2011;11:171.
12. Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med. 2007;356:55-66.
13. Fenollar F, Raoult D. Molecular techniques in Whipple's disease. Expert Rev Mol Diagn. 2001;1:299-309.
14. Fenollar F, Rolain JM, Alric L, Papo T, Chauveheid MP, van de Beek D, Raoult D. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents. 2009;34:255-259.
15. Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology. 2010;138:478-486.
16. Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539-551.
17. Gerard A, Sarrot-Reynauld F, Liozon E, Cathebras P, Besson G, Robin C, Vighetto A, Mosnier JF, Durieu I, Vital Durand D, Rousset H. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore). 2002;81:443-457.
18. Ghigo E, Capo C, Aurouze M, Tung CH, Gorvel JP, Raoult D, Mege JL. Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infect Immun. 2002;70:1501-1506.
19. Herrera C, Myressiotis S, Schoenen J, Ansseau M. EClinical case of the month. Whipple's disease: inaugural psychiatric symptoms. Rev Med Liege. 2001;56:676-680.
20. La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int J Syst Evol Microbiol. 2001;51:1471-1479.
21. Lagier JC, Fenollar F, Lepidi H, Liozon E, Raoult D. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide. J Infect. 2010;60:79-82.
22. Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. J Antimicrob Chemother. 2010;65:2005-2012.
23. Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337-345.
24. Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996;40:561-568.
25. Misbah SA, Ozols B, Franks A, Mapstone M. Whipple's disease without malabsorption: new atypical features. QJM. 1997;90:765-772.
26. Mohamed W, Neil E, Kupsky WJ, Juhasz C, Mittal S, Santhakumar S. Isolated intracranial Whipple's diseaseVreport of a rare case and review of the literature. J Neurol Sci. 2011;308:1-8.
27. Naegeli B, Bannwart F, Bertel O. An uncommon cause of recurrent strokes: Tropheryma whippelii endocarditis. Stroke. 2000;31: 2002-2003.
28. Peters G, du Plessis DG, Humphrey PR. Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology. J Neurol Neurosurg Psychiatry. 2002;73:336-339.
29. Schnider PJ, Reisinger EC, Gerschlager W, Muller C, Berger T, Krejs GJ, Auff E. Long-term follow-up in cerebral Whipple's disease. Eur J Gastroenterol Hepatol. 1996;8:899-903.
30. Vital Durand D, Gerard A, Rousset H. ENeurological manifestations of Whipple disease. Rev Neurol (Paris). 2002;158:988-992.
31. von Herbay A, Ditton HJ, Schuhmacher F, Maiwald M. Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology. 1997;113:434-441.